Ipralin Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Ipratropium Br 20 mcg, salbutamol 100 mcg

Indications/Uses

COPD.

Click to view Ipralin detailed prescribing information

Dosage/Direction for Use

2 puffs qds. Max: 12 puffs in 24 hr.

Click to view Ipralin detailed prescribing information

Contraindications

Hypersensitivity to atropine or its derivatives. History of hypersensitivity to soya lecithin or related food products eg, soybean & peanut.

Click to view Ipralin detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Ipralin detailed prescribing information

Special Precautions

Discontinue immediately if paradoxical bronchospasm occurs. CV disorders especially coronary insufficiency, cardiac arrhythmias & HTN; narrow-angle glaucoma, prostatic hyperplasia or bladder-neck obstruction; convulsive disorders, hyperthyroidism, DM. May produce transient hypokalemia. Hepatic or renal insufficiency. Pregnancy & lactation. Childn.

Click to view Ipralin detailed prescribing information

Use In Pregnancy & Lactation

Click to view Ipralin detailed prescribing information

Adverse Reactions

Headache, pain, influenza, bronchitis, dyspnea, coughing, resp disorders, pneumonia, upper resp tract infection, pharyngitis, sinusitis, rhinitis. Edema, fatigue, HTN, dizziness, nervousness, paresthesia, tremor, dysphonia, insomnia, diarrhea, dry mouth, dyspepsia, vomiting, arrhythmia, palpitation, tachycardia, arthralgia, angina, increased sputum, taste perversion & UTI/dysuria.

Click to view Ipralin detailed prescribing information

Drug Interactions

Potential additive effect in concomitant use w/ anticholinergics. Increased risk of CV adverse effects in concomitant use w/ β-blockers. May worsen ECG changes &/or hypokalemia of non-K sparing diuretics (eg, loop or thiazide diuretics). Potentiated CV action of salbutamol in concomitant use w/ or w/in 2 wk of discontinuation of MAOIs or tricyclic antidepressants.

Click to view Ipralin detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Ipralin detailed prescribing information

Storage

View Ipralin storage conditions for details to ensure optimal shelf-life.

Description

View Ipralin description for details of the chemical structure and excipients (inactive components).

Action

View Ipralin mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03AL02 - salbutamol and ipratropium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Ipralin inhaler 20 mcg/100 mcg

Packing/Price

200 puff x 1's

Ipralin

ipratropium bromide + salbutamol

Manufacturer:

Aristopharma

Distributor:

KTZ